These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 30761256)
1. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma. Ren ZP; Hou XB; Tian XD; Guo JT; Zhang LB; Xue ZQ; Deng JQ; Zhang SW; Pan JY; Chu XY FEBS Open Bio; 2019 Feb; 9(2):315-327. PubMed ID: 30761256 [TBL] [Abstract][Full Text] [Related]
2. miRNA and mRNA Integration Network Construction Reveals Novel Key Regulators in Left-Sided and Right-Sided Colon Adenocarcinoma. Yang L; Li L; Ma J; Yang S; Zou C; Yu X Biomed Res Int; 2019; 2019():7149296. PubMed ID: 31073530 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models. Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990 [TBL] [Abstract][Full Text] [Related]
4. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma. Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071 [TBL] [Abstract][Full Text] [Related]
5. Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis. Wang W; Liu B; Duan X; Feng X; Wang T; Wang P; Ding M; Zhang Q; Feng F; Wu Y; Yao W; Wang Q; Yang Y Comb Chem High Throughput Screen; 2020; 23(2):148-156. PubMed ID: 31976830 [TBL] [Abstract][Full Text] [Related]
6. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis. Wang Y; Fu J; Wang Z; Lv Z; Fan Z; Lei T Cancer Biomark; 2019; 25(4):313-324. PubMed ID: 31322548 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Dong R; Liu J; Sun W; Ping W Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160 [TBL] [Abstract][Full Text] [Related]
8. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles. Yerukala Sathipati S; Ho SY Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of key genes, microRNAs and long non-coding RNAs in hepatocellular carcinoma. Shi B; Zhang X; Chao L; Zheng Y; Tan Y; Wang L; Zhang W FEBS Open Bio; 2018 Sep; 8(9):1424-1436. PubMed ID: 30186744 [TBL] [Abstract][Full Text] [Related]
10. Identification of an Exosome-relevant SNHG6-hsa-miR-429- CHRDL1/CCNA2 Axis for Lung Adenocarcinoma Prognosis Evaluation. Yuan Y; Li Q; Chen F; Zhao Y; Ma J; Fang S Curr Med Chem; 2024; 31(28):4549-4561. PubMed ID: 38994652 [TBL] [Abstract][Full Text] [Related]
11. hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma. Li S; Sun X; Miao S; Lu T; Wang Y; Liu J; Jiao W Thorac Cancer; 2018 Aug; 9(8):924-930. PubMed ID: 29932500 [TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of mRNA, microRNA alteration and aberrant DNA methylation patterns in rectal adenocarcinoma. Hua Y; Ma X; Liu X; Yuan X; Qin H; Zhang X PLoS One; 2017; 12(3):e0174461. PubMed ID: 28350845 [TBL] [Abstract][Full Text] [Related]
13. Identification of circular RNA-microRNA-messenger RNA regulatory network in hepatocellular carcinoma by integrated analysis. Sun X; Ge X; Xu Z; Chen D J Gastroenterol Hepatol; 2020 Jan; 35(1):157-164. PubMed ID: 31222831 [TBL] [Abstract][Full Text] [Related]
14. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma. Tan J; Wang W; Song B; Song Y; Meng Z Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839 [TBL] [Abstract][Full Text] [Related]
15. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma. Gao L; Zhang L BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
17. Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma. Wu J; Feng Z; Wang R; Li A; Wang H; He X; Shen Z Cancer Med; 2022 Dec; 11(23):4411-4421. PubMed ID: 35585716 [TBL] [Abstract][Full Text] [Related]
18. Microarray data analysis to identify miRNA biomarkers and construct the lncRNA-miRNA-mRNA network in lung adenocarcinoma. Song Y; Kelava L; Zhang L; Kiss I Medicine (Baltimore); 2022 Sep; 101(36):e30393. PubMed ID: 36086747 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profile and TNM staging system predict survival in patients with lung adenocarcinoma. Xin G; Cao X; Zhao W; Lv P; Qiu G; Li Y; Wang B; Fang B; Jia Y Math Biosci Eng; 2020 Nov; 17(6):8074-8083. PubMed ID: 33378933 [TBL] [Abstract][Full Text] [Related]
20. Microarray expression profile of microRNAs in lung adenocarcinoma patients with the Cancer Genome Atlas and its clinical validation. Chen G; Xing Y; Peng X; Miao L; Zhao M; Zhou H; Xiao Y J BUON; 2020; 25(2):821-827. PubMed ID: 32521873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]